Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Intellia Therapeutics (NTLA) Assets Average (2016 - 2025)

Intellia Therapeutics (NTLA) has disclosed Assets Average for 10 consecutive years, with $883.7 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 25.25% to $883.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $883.7 million through Dec 2025, down 25.25% year-over-year, with the annual reading at $1.0 billion for FY2025, 18.41% down from the prior year.
  • Assets Average for Q4 2025 was $883.7 million at Intellia Therapeutics, down from $912.1 million in the prior quarter.
  • The five-year high for Assets Average was $1.5 billion in Q1 2023, with the low at $694.6 million in Q2 2021.
  • Average Assets Average over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2024.
  • The sharpest move saw Assets Average soared 131.69% in 2021, then dropped 25.25% in 2025.
  • Over 5 years, Assets Average stood at $1.3 billion in 2021, then decreased by 0.95% to $1.3 billion in 2022, then dropped by 2.31% to $1.3 billion in 2023, then decreased by 7.07% to $1.2 billion in 2024, then decreased by 25.25% to $883.7 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $883.7 million, $912.1 million, and $942.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.